Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional studyJianqiu Wu, Jifeng Feng, Tingchao Chen et al.|BMC Cancer|2016Cited by 32
Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in ChinaJianqiu Wu, Jifeng Feng, Yongping Song et al.|Chinese Medical Journal|2018Cited by 27